Non-Invasive Cancer Diagnosis Market 2017: Global Industry Analysis Report to 2022

The global Non-invasive cancer diagnostics market is expected to grow at the CAGR of 7.2% during 2017-2022. Rising chronic cancers with a growing demand of minimally invasive Diagnostics are driving the non-invasive cancer Diagnostics market across the globe. Non-invasive cancer diagnostic market is an approach used for detection of the cancer conditions with minimal incision in body during diagnosis. According to WHO, 14 million cases of cancer were reported and 8.2 million died in 2012. The numbers of fatalities have been increased to 8.8 million during 2015-16. This significant number of cancer cases has shifted the global attention towards the adoption of early detection and diagnosis techniques for cancer.

Request a Free Sample of our Non-Invasive Cancer Diagnosis Market: https://www.omrglobal.com/request-sample/non-invasive-cancer-diagnostics-market

Additionally, the growing awareness programs and initiatives by government and healthcare organizations are boosting the market growth across the globe. Cancer Research UK, the Department of Health, NHS England and Public Health England in collaboration has launched National Awareness and Early Diagnosis Initiative (NAEDI). The initiative aims to increase awareness of the signs and symptoms of cancer amongst the general public and medical professionals, and to promote early diagnosis. Many more number of such initiatives are creating awareness among global patients for diagnosis and treatment of cancer.

However, high costs of these diagnosis techniques are the major factor hindering the market growth. The government stringent regulations for these techniques are somehow restraints of this market. FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA) have issued ovarian cancer national alliance regulations for regulating non-invasive monitoring devices. Additionally, R&D works in cancer research and its diagnosis along with some technological innovations in techniques are expected in the upcoming years. Liquid biopsy has emerged an innovative and promising non-invasive cancer diagnostic tool for early detection as well as monitoring the disease’s progress in the recent years.

A full Report of Non-Invasive Cancer Diagnosis Market is Available at: https://www.omrglobal.com/industry-reports/non-invasive-cancer-diagnostics-market

• Non-Invasive Cancer Diagnosis MARKET SEGMENTATION

BY TYPE

BLOOD CANCER
SOLID TUMORS
BREAST CANCER
LUNG CANCER
OTHERS

BY TECHNIQUES
•
CLINICAL CHEMISTRY
IMMUNOCHEMISTRY/IMMUNOASSAY
MOLECULAR DIAGNOSTICS
OTHER CLINICAL INSTRUMENT
• COMPETITIVE LANDSCAPE
•
• KEY STRATEGIES

KEY COMPANY ANALYSIS

REGIONAL ANALYSIS
NORTH AMERICA
UNITED STATES
CANADA
REST OF NORTH AMERICA
EUROPE
UNITED KINGDOM
FRANCE
GERMANY
ITALY
SPAIN
REST OF EUROPE
ASIA PACIFIC
INDIA
CHINA
JAPAN
• REST OF THE WORLD
•
COMPANY PROFILES

A&G PHARMACEUTICAL, INC.
INTRODUCTION
A7G PHARMACEUTICAL PRODUCT PORTFOLIO
A&G PHARMACEUTICAL RECENT ACTIVITIES
ACCELERATE BRAIN CANCER CURE
INTRODUCTION
ACCELERATE BRAIN CANCER CURE PRODUCT PORTFOLIO
ACCELERATE BRAIN CANCER CURE RECENT ACTIVITIES
ADMERA HEALTH INNOVATIONS
INTRODUCTION
ADMERA HEALTH INNOVATIONS PRODUCT PORTFOLIO
ADMERA HEALTH INNOVATIONS RECENT ACTIVITIES
AFFYMETRIX INC.
INTRODUCTION
AFFYMETRIX INC. PRODUCT PORTFOLIO
AFFYMETRIX INC. RECENT ACTIVITIES
AVIVA BIOSCIENCES CORPORATION
INTRODUCTION
AVIVA BIOSCIENCES CORPORATION PRODUCT PORTFOLIO
AVIVA BIOSCIENCES CORPORATION RECENT ACTIVITIES
BIOVIEW INC.
INTRODUCTION
BIOVIEW INC. PRODUCT PORTFOLIO
BIOVIEW INC. RECENT ACTIVITIES
CYNVENIO BIOSYSTEMS
INTRODUCTION
CYNVENIO BIOSYSTEMS PRODUCT PORTFOLIO
CYNVENIO BIOSYSTEMS RECENT ACTIVITIES
DIGENE CORPORATION
INTRODUCTION
DIGENE CORPORATION PRODUCT PORTFOLIO
DIGENE CORPORATION RECENT ACTIVITIES
EXOSOMICS SIENA
INTRODUCTION
EXOSOMICS SIENA PRODUCT PORTFOLIO
EXOSOMICS SIENA RECENT ACTIVITIES
FLARITON HEALTH
INTRODUCTION
FLARITON HEALTH PRODUCT PORTFOLIO
FLARITON HEALTH RECENT ACTIVITIES
GEN-PROBE INCORPORATED
INTRODUCTION
GEN-PROBE INCORPORATED PRODUCT PORTFOLIO
GEN-PROBE INCORPORATED RECENT ACTIVITIES
IV DIAGNOSTICS, INC.
INTRODUCTION
IV DIAGNOSTICS, INC. PRODUCT PORTFOLIO
IV DIAGNOSTICS, INC. RECENT ACTIVITIES
LABCORP
INTRODUCTION
LABCORP PRODUCT PORTFOLIO
LABCORP RECENT ACTIVITIES
NEOGENOMICS
INTRODUCTION
NEOGENOMICS PRODUCT PORTFOLIO
NEOGENOMICS RECENT ACTIVITIES
NOVARTIS
INTRODUCTION
NOVARTIS PRODUCT PORTFOLIO
NOVARTIS RECENT ACTIVITIES
NOVIGENIX
INTRODUCTION
NOVIGENIX PRODUCT PORTFOLIO
NOVIGENIX RECENT ACTIVITIES
PRECISION THERAPEUTICS, INC.
INTRODUCTION
PRECISION THERAPEUTICS, INC.PRODUCT PORTFOLIO
PRECISION THERAPEUTICS, INC.RECENT ACTIVITIES
QIAGEN
INTRODUCTION
QIAGENPRODUCT PORTFOLIO
QIAGENRECENT ACTIVITIES
QUANTERIX
INTRODUCTION
QUANTERIX PRODUCT PORTFOLIO
QUANTERIX RECENT ACTIVITIES
QUEST DIAGNOSTICS INC.,
INTRODUCTION
QUEST DIAGNOSTICS INC., PRODUCT PORTFOLIO
QUEST DIAGNOSTICS INC., RECENT ACTIVITIES

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-invasive-cancer-diagnostics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.